8i Acquisition 2 Corp. focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses primarily in Asia. The company was incorporated in 2021 and is based in Singapore.
IPO Year: 2021
Exchange: NASDAQ
Singapore, Nov. 23, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the "Business Combination") with EUDA Health Ltd ("EUDA Health"), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare. The combined company will operate under the name "EUDA Health Holdings Limited" (NASDAQ:EUDA) and will be led by Founder and Chief Executive Officer Dr. Kelvin Chen. Commencing at the open of trading on N
Singapore, Nov. 17, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, today announced the completion of its business combination (the "Business Combination") with EUDA Health Limited ("EUDA Health"), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare. The combined company will operate under the name "EUDA Health Holdings Limited" and will be led by Founder and Chief Executive Officer Dr. Kelvin Chen. Commencing at the open of trading on November 18, 202
Singapore, Nov. 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (NASDAQ:LAX, the "Company"))), a special purpose acquisition company, announced today that all proposals presented to shareholders at the special meeting of shareholders held on November 10, 2022 at 10:00 a.m. Eastern Time relating to the Company's business combination with EUDA Health Limited were approved by shareholders. Holders of Company's ordinary shares that elected to redeem shares in connection with the Company's special meeting of shareholders may withdraw such redemption requests by no later than 5:00 p.m. Eastern Time on November 11, 2022. Based on a total of 8,195,770 ordinary shares tendered for redemption in
Singapore, June 10, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited ("EUDA Health"), a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare, today announced an amendment to the Share Purchase Agreement (the "SPA Amendment") to, among other things, reduce the consideration payable by LAX to EUDA Health, and limit the earn-out payment available to the seller of EUDA Health in connection with the Share Purchase. As previously announce
Singapore, May 31, 2022 (GLOBE NEWSWIRE) -- 8i Acquisition 2 Corp. (the "Company" or "LAX") (NASDAQ:LAX), a publicly traded special purpose acquisition company, and EUDA Health Limited, a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare, today announced an amendment to the SPA (the "SPA Amendment") to extend the time for LAX to complete its financial, operational and legal due diligence review of EUDA Health from May 31, 2022 to June 15, 2022. As previously announced, LAX entered into a Share Purchase Agreement (the "SPA") dated April 11, 20
EUDA Health is disrupting the multi-trillion-dollar Southeast Asia healthcare industry with its proprietary unified AI platform that makes healthcare affordable, accessible, and personalized across Southeast Asia— one of the fastest growing healthcare technology markets in the world Pro forma enterprise value of the combined company is expected to be approximately $580 million with cash on hand of approximately $90 million, assuming no redemptions Singapore, April 12, 2022 (GLOBE NEWSWIRE) -- EUDA Health Limited, a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through pe
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
424B3 - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
EFFECT - EUDA Health Holdings Ltd (0001847846) (Filer)
F-1/A - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
F-1/A - EUDA Health Holdings Ltd (0001847846) (Filer)
6-K - EUDA Health Holdings Ltd (0001847846) (Filer)
4 - EUDA Health Holdings Ltd (0001847846) (Issuer)
3 - EUDA Health Holdings Ltd (0001847846) (Issuer)
4 - EUDA Health Holdings Ltd (0001847846) (Issuer)
3 - EUDA Health Holdings Ltd (0001847846) (Issuer)
4 - EUDA Health Holdings Ltd (0001847846) (Issuer)
3 - EUDA Health Holdings Ltd (0001847846) (Issuer)
3 - EUDA Health Holdings Ltd (0001847846) (Issuer)
4 - EUDA Health Holdings Ltd (0001847846) (Issuer)
3 - EUDA Health Holdings Ltd (0001847846) (Issuer)
3 - EUDA Health Holdings Ltd (0001847846) (Issuer)
SC 13D/A - EUDA Health Holdings Ltd (0001847846) (Subject)
SC 13G/A - EUDA Health Holdings Ltd (0001847846) (Subject)
SC 13G/A - EUDA Health Holdings Ltd (0001847846) (Subject)
SC 13G/A - EUDA Health Holdings Ltd (0001847846) (Subject)
SC 13D - EUDA Health Holdings Ltd (0001847846) (Subject)
SC 13D - EUDA Health Holdings Ltd (0001847846) (Subject)
SC 13G - EUDA Health Holdings Ltd (0001847846) (Subject)
SC 13G/A - 8i Acquisition 2 Corp. (0001847846) (Subject)
SC 13G - 8i Acquisition 2 Corp. (0001847846) (Subject)
SC 13G - 8i Acquisition 2 Corp. (0001847846) (Subject)
Gainers ShiftPixy, Inc. (NASDAQ:PIXY) shares surged 56.6% to settle at $19.10 on Friday. Shares of several companies in the broader industrial space traded higher on continued hopes of softer Fed policy after CPI this week showed October inflation below estimates. Exela Technologies, Inc. (NASDAQ:XELA) gained 50.3% to close at $0.2780. The company is expected to report Q3 results on November 14, 2022. uCloudlink Group Inc. (NASDAQ:UCL) jumped 49.6% to close at $1.90. uCloudlink Group is expected to report Q3 financial results on November 16, 2022. Core Scientific, Inc. (NASDAQ:CORZ) gained 44.3% to settle at $0.1981. Compass, Inc. (NYSE:COMP) jumped 44% to close at $3.50. Compass po
Gainers Snail, Inc. (NASDAQ:SNAL) shares jumped 74.9% to $3.9350 after the company announced a $5 million share repurchase program. AGBA Acquisition Limited (NASDAQ:AGBA) gained 70% to $9.35 after dipping 50% on Thursday. AGBA Acquisition announced approval of business combination and ability of stockholders to withdraw ordinary shares tendered for redemption. Compass, Inc. (NYSE:COMP) surged 56% to $3.80. Compass posted a wider-than-expected loss for its third quarter, while sales topped estimates. Mercurity Fintech Holding Inc. (NYSE:MFH) jumped 39% to $0.6994 afetr dropping 26% on Thursday. Hillstream BioPharma, Inc. (NASDAQ:HILS) gained 35.8% to $0.5092. TransAct Technologies Inc
Gainers Fast Radius, Inc. (NASDAQ:FSRD) shares jumped 156.2% to close at $0.2608 on Thursday after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's voluntary Chapter 11 petitions filed on November 7. SHF Holdings, Inc. (NASDAQ:SHFS) jumped 86.7% to close at $3.79 on Thursday. EpicQuest Education Group International Limited (NASDAQ:EEIQ) rose 72.1% to close at $1.79. Magnite, Inc. (NASDAQ:MGNI) shares surged 65.6% to close at $9.57 after the company reported better-than-expected Q3 results. TG Therapeutics, Inc. (NASDAQ:TGTX) jumped 63.4% to close at $8.43 following narrower-than-expected Q3 loss. Digital Turbine,
8i Acquisition 2 Corp. (NASDAQ:LAX, the &ldquo, Company&rdquo, ))), a special purpose acquisition company, announced today that all proposals presented to shareholders at the special meeting of shareholders held on November 10, 2022 at 10:00 a.m. Eastern Time relating to the Company’s business combination with EUDA Health Limited were approved by shareholders. Holders of Company’s ordinary shares that elected to redeem shares in connection with the Company’s special meeting of shareholders may withdraw such redemption requests by no later than 5:00 p.m. Eastern Time on November 11, 2022. Based on a total of 8,195,770 ordinary shares tendered for redemption in connection the special meeting o
Gainers Fast Radius, Inc. (NASDAQ:FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wednesday. Fast Radius received Bankruptcy court approval of first day motions related to the company's voluntary Chapter 11 petitions filed on November 7. EpicQuest Education Group International Limited (NASDAQ:EEIQ) gained 80% to $1.8728. Magnite, Inc. (NASDAQ:MGNI) shares jumped 45.7% to $8.42 after the company reported better-than-expected Q3 results. Digital Turbine, Inc. (NASDAQ:APPS) shares jumped 44.8% to $15.59 after reporting upbeat Q2 earnings. Repay Holdings Corporation (NASDAQ:RPAY) gained 42.2% to $6.23 after the company reported upbeat Q3 results. TG Therapeutics, Inc. (NASDA
EUDA Health Limited, a Singapore-based digital health platform that aims to make healthcare more affordable, accessible, and improve the patient experience by delivering improved outcomes through personalized healthcare, and 8i Acquisition 2 Corp. (8i) (NASDAQ:LAX), a publicly traded special purpose acquisition company, announced today that they have entered into a definitive business combination agreement that will result in EUDA Health Limited becoming a publicly listed company. Upon the close of the transaction, LAX will be renamed EUDA Health Limited (EUDA Health) and is expected to remain listed on NASDAQ under the new ticker symbol "EUDA". EUDA Health operates a first-of-its-kind S